Pharmaceuticals

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Trend Stats

1-Month Return +3.82%
3-Month Return +9.53%
12-Month Return +29.64%
Volatility Score 1.8
RSI 52.8
ST Trend Neutral
LT Trend Up

Short-Term Trend

Neutral

The Short-Term Trend is a metric that gauges an ETF's short-term price trend.

Long-Term Trend

Up

The Long-Term Trend is a metric that gauges an ETF's long-term price trend.

Performance

Pharmaceuticals
S&P 500 Index

Components

Symbol Company Market Cap 12 mo return Performance over the past 12 months 3 mo return Performance over the past 3 months 1 mo return Performance over the past month Vol Score Our gauge of the ETF's recent volatility ST Trend A metric that gauges an ETF's short-term price trend LT Trend A metric that gauges an ETF's long-term price trend
LLY Eli Lilly & Co $1.1T +69.36% +17.60% +2.54% 3.4 Neutral Up
JNJ Johnson&Johnson $627B +51.07% +13.45% +2.56% 2.2 Up Up
ABBV AbbVie $441B +24.44% +19.20% +2.64% 2.4 Neutral Up
MRK Merck $335B +66.70% +20.64% +12.47% 2.4 Up Up
NVS Novartis Sp ADR $287B +25.14% +0.74% +0.35% 2.1 Down Up
AZN ASTRAZENECA $243B +0.50% -14.85% -4.26% 2.6 Down Down
NVO Nordisk Sp ADR-B $201B -8.36% +0.20% -6.48% 3.5 Down Neutral
PFE Pfizer $153B +14.04% +5.86% +12.41% 2.0 Up Up
BMY Bristol-MyersSqu $130B +38.10% +13.71% +12.08% 2.7 Up Up
SNY SANOFI SP ADR $105B -7.29% +2.03% +1.25% 2.0 Neutral Down
MCK Mckesson $101B +29.64% +16.42% +8.17% 3.1 Up Up
GSK GSK Sp ADR $99B +30.28% -1.06% -2.50% 2.5 Down Down
COR Cencora $60B +7.99% +20.70% +4.02% 2.9 Up Down
TAK TAKEDA PHARM SP ADR $56B +22.24% +6.01% +7.57% 2.0 Up Up
TEVA TEVAPHARMIND SP ADR $43B +105.88% +4.13% +15.56% 3.1 Up Up
HLN Haleon Sp ADR $43B +2.55% +9.58% +0.66% 2.0 Neutral Neutral
ZTS Zoetis-A $30B -51.20% -1.56% +0.32% 3.9 Down Down
VTRS Viatris $19B +59.00% -5.28% -0.49% 3.3 Down Up
JAZZ Jazz Pharmaceuti $16B +108.00% +6.02% +2.90% 3.1 Neutral Up
CORT Corcept Therapeu $12B +59.55% +96.35% +26.53% 4.8 Up Up
ELAN ELANC ANIML HLTH $12B +31.79% +9.38% -7.36% 4.8 Down Neutral
AXSM Axsome Therapeut $11B +95.64% -8.01% -9.18% 4.3 Down Up
OGN Organon $3.6B +46.52% +2.84% +1.78% 0.3 Neutral Up
BHC BAUSCH HEALTH $2.4B -21.94% +19.45% +37.05% 5.9 Up Up
PRGO Perrigo $1.8B -37.65% +23.42% +31.72% 4.7 Up Up